Our results demonstrate the potential of combining biomarkers that represent microenvironmental elements like immune infiltration and angiogenesis as well as tumor-intrinsic (cell-autonomous) changes like EGFR amplification and IDH mutations (Heterogeneity, 2025). The gene discussed is IDH1; the disease is neoplasm.